[SEVERE NEUROLOGICAL SIDE-EFFECTS IN HYPOTENSION THERAPY].
D000654:Amobarbital; D000959:Antihypertensive Agents; D001161:Arteriosclerosis; D002740:Chlorothiazide; D002752:Chlorthalidone; D006145:Guanethidine; D006429:Hemiplegia; D006801:Humans; D006830:Hydralazine; D006852:Hydrochlorothiazide; D006973:Hypertension; D007022:Hypotension; D008750:Methyldopa; D009461:Neurologic Manifestations; D012110:Reserpine; D014116:Toxicology
D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D002740:Chlorothiazide; D012110:Reserpine; D000654:Amobarbital; D002752:Chlorthalidone; D006145:Guanethidine
AMOBARBITAL; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; CHLOROTHIAZIDE; CHLORTHALIDONE; GUANETHIDINE; HEMIPLEGIA; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYPERTENSION; METHYLDOPA; NEUROLOGIC MANIFESTATIONS; RESERPINE; TOXICOLOGIC REPORT
SVARA NEUROLOGISKA BIVERKNINGAR VID HYPERTENSIONSBEHANDLING.